Effect of Esketamine on Postoperative Cognitive Function in Patients Undergoing Partial Hepatic Resection with Controlled Low Central Venous Pressure: A Prospective Cohort Study

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300078120

Enrollment

Unknown

Registered

2023-11-29

Start date

2023-12-01

Completion date

Unknown

Last updated

2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Esketamine group:NA

Control group:NA

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Scheduled laparoscopic partial hepatic resection; Age= 18; ASA (American Society of Anesthesiologists) II, III.

Exclusion criteria

Exclusion criteria: NYHA = 3, Child-Pugh =C, operation time 6h, central nervous system diseases, vision or hearing abnormalities that cannot communicate, Admitted to ICU after surgery, participation in another research.

Design outcomes

Primary

Measure	Time frame
Postoperative delirium; postoperative cognitive function; Systemic inflammation indicator;Hemodynamic indicators;	—

Countries

China

Contacts

Public ContactLi Jin

The Second Hospital of Hebei Medical University

happyyky@163.com+86 139 3111 3354

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026